PolySciTech (www.polyscitech.com) carries a variety of
mPEG-PLGA (e.g. polyvivo AK02), mPEG-PCL (e.g. polyvivo AK01), and
PLGA-fluorescein conjugates (Polyvivo AV04). Recently these same types of
polymers were utilized to develop a chremophor-EL free, nanoparticle based
delivery system for paclitaxel and to validate it in terms of cellular uptake
and in-vivo effectiveness against tumer lines. Read more: Danhier, Fabienne,
Nathalie Lecouturier, Benoît Vroman, Christine Jérôme, Jacqueline
Marchand-Brynaert, Olivier Feron, and Véronique Préat. "Paclitaxel-loaded
PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation."
Journal of Controlled Release 133, no. 1 (2009): 11-17. http://dx.doi.org/10.1016/j.jconrel.2008.09.086
“Abstract The purpose of this
study was to develop Cremophor® EL-free nanoparticles loaded with Paclitaxel
(PTX), intended to be intravenously administered, able to improve the
therapeutic index of the drug and devoid of the adverse effects of Cremophor®
EL. PTX-loaded PEGylated PLGA-based were prepared by simple emulsion and
nanoprecipitation. The incorporation efficiency of PTX was higher with the
nanoprecipitation technique. The release behavior of PTX exhibited a biphasic
pattern characterized by an initial burst release followed by a slower and
continuous release. The in vitro anti-tumoral activity was assessed using the
Human Cervix Carcinoma cells (HeLa) by the MTT test and was compared to the
commercial formulation Taxol® and to Cremophor® EL. When exposed to 25 µg/ml of
PTX, the cell viability was lower for PTX-loaded nanoparticles than for Taxol®
(IC50 5.5 vs 15.5 µg/ml). Flow cytometry studies showed that the cellular
uptake of PTX-loaded nanoparticles was concentration and time dependent.
Exposure of HeLa cells to Taxol® and PTX-loaded nanoparticles induced the same
percentage of apoptotic cells. PTX-loaded nanoparticles showed greater tumor
growth inhibition effect in vivo on TLT tumor, compared with Taxol®. Therefore,
PTX-loaded nanoparticles may be considered as an effective anticancer drug
delivery system for cancer chemotherapy. Keywords Paclitaxel; PEGylated
nanoparticle; PLGA; Anti-tumoral activity”
No comments:
Post a Comment